{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T08:24:05Z","timestamp":1786955045244,"version":"build-2736575974"},"reference-count":14,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T00:00:00Z","timestamp":1770076800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,4,26]]},"DOI":"10.1093\/jbmr\/zjag023","type":"journal-article","created":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T12:35:03Z","timestamp":1769949303000},"page":"459-460","source":"Crossref","is-referenced-by-count":0,"title":["Concurrent administration of teriparatide and denosumab: attenuation of bone accrual?"],"prefix":"10.1093","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1910-788X","authenticated-orcid":false,"given":"Jacques P","family":"Brown","sequence":"first","affiliation":[{"name":"Department of Medicine, Universit\u00e9 Laval , Quebec, QC, G1V 0A6 ,","place":["Canada"]},{"name":"Infectious and Immune Diseases, CHU de Qu\u00e9bec-Universit\u00e9 Laval Research Centre , Quebec, QC, G1V 4G2 ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,2,3]]},"reference":[{"issue":"10","key":"2026081703271350100_ref1","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1093\/jbmr\/zjae110","article-title":"Osteoclast-derived coupling factors: origins and state-of-play Louis V Avioli lecture, ASBMR 2023","volume":"39","author":"Sims","year":"2024","journal-title":"J Bone Miner Res"},{"issue":"6","key":"2026081703271350100_ref2","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1177\/1759720X16670154","article-title":"Bone modeling and remodeling: potential as therapeutic targets for the treatment of osteoporosis","volume":"8","author":"Langdahl","year":"2016","journal-title":"Ther Adv Musculoskelet Dis"},{"issue":"15","key":"2026081703271350100_ref3","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1001\/archinte.165.15.1762","article-title":"Opposite bone remodeling effects of teriparatide and alendronate in increasing bone mass","volume":"165","author":"McClung","year":"2005","journal-title":"Arch Intern Med"},{"issue":"3","key":"2026081703271350100_ref4","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1210\/jc.2002-021988","article-title":"Effects of intermittent parathyroid hormone administration on bone mineralization density in iliac crest biopsies from patients with osteoporosis: a paired study before and after treatment","volume":"88","author":"Misof","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"2026081703271350100_ref5","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1002\/jbmr.2804","article-title":"A longitudinal study of skeletal histomorphometry at 6 and 24 months across four bone envelopes in postmenopausal women with osteoporosis receiving teriparatide or zoledronic acid in the SHOTZ trial","volume":"31","author":"Dempster","year":"2016","journal-title":"J Bone Miner Res"},{"issue":"4","key":"2026081703271350100_ref6","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1359\/JBMR.040112","article-title":"Teriparatide [PTH(1-34)] strengthens the proximal femur of ovariectomized nonhuman primates despite increasing porosity","volume":"19","author":"Sato","year":"2004","journal-title":"J Bone Miner Res"},{"issue":"5","key":"2026081703271350100_ref7","doi-asserted-by":"publisher","first-page":"1694","DOI":"10.1210\/jc.2013-4440","article-title":"Two years of denosumab and teriparatide administration in postmenopausal women with osteoporosis (the DATA extension study): a randomized controlled trial","volume":"99","author":"Leder","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2026081703271350100_ref8","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.1210\/jc.2016-1160","article-title":"Effects of two years of teriparatide, denosumab, or both on bone microarchitecture and strength (DATA-HRpQCT study)","volume":"101","author":"Tsai","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2026081703271350100_ref9","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1002\/jbm4.10041","article-title":"Optimizing sequential and combined anabolic and antiresorptive osteoporosis therapy","volume":"2","author":"Leder","year":"2018","journal-title":"JBMR Plus"},{"key":"2026081703271350100_ref10","doi-asserted-by":"publisher","DOI":"10.1093\/jbmr\/zjaf152","article-title":"Comparative bone histomorphometry effects of combined denosumab and teriparatide versus monotherapy in postmenopausal women with osteoporosis: a randomized controlled trial","author":"Ramchand","year":"2025","journal-title":"J Bone Miner Res"},{"issue":"1","key":"2026081703271350100_ref11","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.ajpath.2013.03.006","article-title":"Understanding coupling between bone resorption and formation: are reversal cells the missing link?","volume":"183","author":"Andersen","year":"2013","journal-title":"Am J Pathol"},{"issue":"12","key":"2026081703271350100_ref12","doi-asserted-by":"publisher","first-page":"2411","DOI":"10.1007\/s00198-025-07612-z","article-title":"The cellular effect of intermittent PTH treatment on bone remodeling and modeling in humans-a histomorphometry centered scoping review","volume":"36","author":"Thomsen","year":"2025","journal-title":"Osteoporos Int"},{"issue":"12","key":"2026081703271350100_ref13","doi-asserted-by":"publisher","DOI":"10.1210\/endocr\/bqae142","article-title":"Evaluation of osteogenic phenotype in postmenopausal women receiving anabolic and antiresorptive osteoporosis therapies","volume":"165","author":"Kobelski","year":"2024","journal-title":"Endocrinology."},{"issue":"36","key":"2026081703271350100_ref14","doi-asserted-by":"publisher","first-page":"28164","DOI":"10.1074\/jbc.M110.101964","article-title":"Are osteoclasts needed for the bone anabolic response to parathyroid hormone? A study of intermittent parathyroid hormone with denosumab or alendronate in knock-in mice expressing humanized RANKL","volume":"285","author":"Pierroz","year":"2010","journal-title":"J Biol Chem"}],"container-title":["Journal of Bone and Mineral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jbmr\/advance-article-pdf\/doi\/10.1093\/jbmr\/zjag023\/66725109\/zjag023.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jbmr\/article-pdf\/41\/5\/459\/66725109\/zjag023.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jbmr\/article-pdf\/41\/5\/459\/66725109\/zjag023.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T07:27:17Z","timestamp":1786951637000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jbmr\/article\/41\/5\/459\/8456227"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,3]]},"references-count":14,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,2,3]]},"published-print":{"date-parts":[[2026,4,26]]}},"URL":"https:\/\/doi.org\/10.1093\/jbmr\/zjag023","relation":{},"ISSN":["0884-0431","1523-4681"],"issn-type":[{"value":"0884-0431","type":"print"},{"value":"1523-4681","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,5]]},"published":{"date-parts":[[2026,2,3]]}}}